Cargando…
Downregulation of CXCR4 Expression and Functionality After Zoledronate Exposure in Canine Osteosarcoma
BACKGROUND: The establishment and progression of metastases remains the life‐limiting factor for dogs diagnosed with osteosarcoma (OS). The pattern of metastases is likely regulated through interactions between chemokine receptors and chemokines, and perturbations in these signaling cascades respons...
Autores principales: | Byrum, M.L., Pondenis, H.C., Fredrickson, R.L., Wycislo, K.L., Fan, T.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089657/ https://www.ncbi.nlm.nih.gov/pubmed/27251585 http://dx.doi.org/10.1111/jvim.14257 |
Ejemplares similares
-
The Association of Endothelin‐1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma
por: Neumann, Z.L., et al.
Publicado: (2015) -
Pro‐tumorigenic Effects of Transforming Growth Factor Beta 1 in Canine Osteosarcoma
por: Portela, R.F., et al.
Publicado: (2014) -
Expression of Nociceptive Ligands in Canine Osteosarcoma
por: Shor, S., et al.
Publicado: (2015) -
Zoledronate‐Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma
por: Lundberg, A.P., et al.
Publicado: (2016) -
The Immunotherapy of Canine Osteosarcoma: A Historical and Systematic Review
por: Wycislo, K.L., et al.
Publicado: (2015)